Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Intensive Care Medicine (2021) - Comments
pubmed: 34251506  doi: 10.1007/s00134-021-06448-5  issn: 0342-4642  issn: 1432-1238 

Yaseen M. Arabi, Anthony C. Gordon, Lennie P. G. Derde, Alistair D. Nichol, Srinivas Murthy, Farah Al Beidh, Djillali Annane, Lolowa Al Swaidan, Abi Beane, Richard Beasley, Lindsay R. Berry, Zahra Bhimani, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Meredith Buxton, Adrian Buzgau, Allen Cheng, Menno De Jong, Michelle A. Detry